[Skip to Content]
[Skip to Content Landing]
February 10, 1984

Percutaneous Transluminal Angioplasty

Author Affiliations

From the Council on Scientific Affairs, Division of Scientific Activities, American Medical Association, Chicago.

JAMA. 1984;251(6):764-768. doi:10.1001/jama.1984.03340300056031

BECAUSE the technique of percutaneous transluminal angioplasty (PTA) has therapeutic potential and is of increasing interest to physicians,1-3 the American Medical Association's Council on Scientific Affairs, in December 1981, established a panel to review medical knowledge about this new technique and to assess experience with it to date. The Council requested that the panel report on the therapeutic use of PTA in the iliofemoral, coronary, and renal artery beds. The panel's report follows.

PTA—The Procedure  The main principle of PTA is the same, whether the procedure is used in the iliofemoral, renal, or coronary artery bed.2 A double-lumen dilation catheter, with a strong, nonelastic balloon made of polyvinyl chloride or polyethylene annealed to the tip, is introduced into a mainstream vessel, either directly through the skin or by cutdown. Then the catheter is guided to the site of the lesion and positioned so that the balloon segment lies